Baycol Injuries Class Action Lawsuit
Result: Confidential settlements
Year: 2006
In re Baycol Products Litigation
Baycol was one of a group of drugs called statins, intended to reduce cholesterol. In August 2001, Bayer A.G. and Bayer Corporation, the manufacturers of Baycol, withdrew the drug from the worldwide market based upon reports that Baycol was associated with serious side effects and linked to the deaths of over 100 patients worldwide.
In the federal multi-district litigation, Lieff Cabraser served as a member of the Plaintiffs’ Steering Committee (PSC) and the Executive Committee of the PSC. In addition, Lieff Cabraser represented approximately 200 Baycol patients who suffered injuries or family members of patients who died allegedly as a result of ingesting Baycol. In these cases, our clients reached confidential favorable settlements with Bayer.
Civil Litigation News
Court Grants Final Approval to Settlement in Kona Coffee Class Action Advertising Fraud Litigation
U.S. District Judge Robert S. Lasnik of the Western District of Washington at Seattle has granted final approval to the latest and
Court Once Again Rules Against Volkswagen in Dutch Dieselgate Proceedings
Company must pay Consumer €4,440.00, Dutch Consumer Group – the Consumentenbond – Calls for Settlement Talks On Friday October 6, 2023, the
Mark Chalos Selected as Co-Lead Counsel for Plaintiffs in Generac Solar Power Systems Marketing Practice and Products Liability Litigation
The Generac Solar Energy Systems litigation focuses on allegations that energy tech giant Generac’s PWRECell System components are defective and potentially dangerous
